Cefuroxime concentrations in facial artery musculomucosal flap, buccal submucosa, subcutaneous tissue, and plasma following bolus or continuous infusion in patients undergoing oral cancer resection: a randomized clinical microdialysis study
A daily dose of 4500 mg cefuroxime provides adequate tissue and plasma concentrations with both BI and CI to achieve ≥50%T > MIC in patients undergoing oral cavity cancer surgery with FAMM flap reconstruction. CI provided more consistent exposure and may offer pharmacokinetic advantages in selected high-risk situations/patients.
Authors
- Pelle Hanberg (ORCID: https://orcid.org/0000-0002-6845-1874)
- Eva Greibe (ORCID: https://orcid.org/0000-0002-0417-1195)
- Jennifer K. Hansen (ORCID: https://orcid.org/0000-0002-0060-6905)
- Arunas Pikelis
- S. Hillerup
- Søren Dürr Gade
- Tejs Ehlers Klug
Institutions
- Aarhus University (DK)
- Aarhus University Hospital (DK)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2026-02-24
- DOI
- https://doi.org/10.1093/jac/dkag085
- Primary Topic
- Oral health in cancer treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00